Clinical Policy: Wireless Motility Capsule
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.143 alerts
Get alerted when Policy CP.MP.143 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and coverage stance for use of the wireless motility capsule (WMC) to evaluate suspected gastric and intestinal motility disorders for Arizona Complete Health members.
No material clinical or coverage changes in this revision.
Coverage Criteria
General coverage stance
Covered when ALL of the following are met
Policy basis: paucity of peer‑reviewed, evidence‑based literature demonstrating diagnostic performance and clinical utility superior to conventional gastric emptying tests.
The wireless motility capsule (WMC) should not be used in patients with a possible stricture, altered gastrointestinal anatomy, or severe pyloric stenosis. The device carries a risk of delayed transit or failure to pass, which can necessitate serial radiographs or endoscopic/surgical removal. These safety limitations are explicit contraindications to testing with the capsule and inform the policy exclusions for use in these populations.
Per this policy, the wireless motility capsule (WMC) is designated not medically necessary for the evaluation of suspected gastric and intestinal motility disorders and for all other indications. The policy states there is a paucity of peer‑reviewed, evidence‑based literature demonstrating that the diagnostic performance and clinical utility of WMC surpass conventional methods of measuring gastric emptying; therefore coverage for WMC is not supported.
Coding
| 91112 | Gastrointestinal transit and pressure measurement, stomach through colon, wireless capsule, with interpretation and report |
| No codes listed |
| No codes listed |
Provider Actions and Billing Guidance
Prior Authorization Expectation
Prior authorization is expected for requests to perform wireless motility capsule (WMC) testing (CPT 91112). WMC is designated not medically necessary for the evaluation of suspected gastric and intestinal motility disorders and other indications per policy. Prior authorization requests for CPT 91112 will generally be denied in the absence of clearly documented, exceptional clinical circumstances supporting medical necessity.
- Affected code: CPT 91112
Coding and Clinical Documentation
If performed and billed, use CPT 91112 (Gastrointestinal transit and pressure measurement, stomach through colon, wireless capsule) with an appropriate interpretation and formal report documented in the medical record. Clinical documentation should include indication for testing, prior diagnostic testing and results, relevant symptoms and duration, contraindications considered (e.g., strictures, altered anatomy, severe pyloric stenosis), medication management (e.g., PPI/H2 blockers held if applicable), and any factors that would justify use despite the policy designation.
- Billing code: CPT 91112 — include interpretation and report
- Document: indication, prior tests/results, symptoms/duration, medication holding, contraindication assessment, rationale if seeking exception
Preferred / Established Alternatives
Preferred and established alternative tests should be considered prior to ordering WMC. Scintigraphic gastric emptying of solids remains the standard for evaluation of gastric emptying and diagnosis of gastroparesis. Other alternative approaches include 13C-spirulina breath testing and radiopaque marker testing for colonic transit, as well as conventional transit studies.
- Preferred alternative: Scintigraphic gastric emptying of solids (standard test)
- Other alternatives: 13C-spirulina breath test; radiopaque marker testing; conventional transit studies
Background
The wireless motility capsule (WMC) is an orally ingested, nondigestible, battery‑powered data‑recording capsule that continuously measures pH, pressure, and temperature while transiting the gastrointestinal tract. The patient swallows the capsule after a standard meal and wears an external recorder that captures telemetry until the capsule exits the body. The device dimensions are approximately 26 x 13 mm with a battery life of about 5 days; an established gastric emptying cutoff for the WMC is ≥ 300 minutes. The capsule identifies regional transit events by characteristic changes in pH (for example, a sharp pH rise on entry into the duodenum and a fall at the ileocecal junction), although a pH drop at the ileocecal region is not observed in about 15% of patients.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.